Plasmacytoid Dendritic Cells and Immunotherapy in Multiple Sclerosis

Felipe von Glehn; Leonilda M Santos; Konstantin E Balashov

Disclosures

Immunotherapy. 2012;4(10):1053-1061. 

In This Article

Conclusion

Although many questions need to be addressed, modulation of pDC function has become a possible approach to restore impaired immune regulation in MS. Nevertheless, the exact role of these complicated cells in MS remains to be defined; the rationale for pDC transfusion as well as the need of pharmacological treatments affecting pDC function in MS have to be determined.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....